Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Incorporation of a Toll-like receptor 2/6 agonist potentiates mRNA vaccines against cancer and infectious diseases
Yangzhuo Gu, H. J. Yang, Cai He, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 25

Showing 25 citing articles:

Decoding Toll-like receptors: Recent insights and perspectives in innate immunity
Taro Kawai, Moe Ikegawa, Daisuke Ori, et al.
Immunity (2024) Vol. 57, Iss. 4, pp. 649-673
Open Access | Times Cited: 69
Harnessing innate immune pathways for therapeutic advancement in cancer
An-Kang Hu, Li Sun, Hao Lin, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 42
mRNA therapies: Pioneering a new era in rare genetic disease treatment
Guobo Shen, Jian Liu, Hanmei Yang, et al.
Journal of Controlled Release (2024) Vol. 369, pp. 696-721
Closed Access | Times Cited: 11
Development of a novel multi-epitope mRNA vaccine candidate to combat HMPV virus
Shiyang Ma, Fei Zhu, Yizhong Xu, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 10
Optimized lipid nanoparticles (LNPs) for organ-selective nucleic acids delivery in vivo
Tian Zhang, Han Yin, Li Yu, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109804-109804
Open Access | Times Cited: 10
Research Advances of Lipid Nanoparticles in the Treatment of Colorectal Cancer
Junyi Zhang, Kamran Ali, Jianwei Wang
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 6693-6715
Open Access | Times Cited: 6
mRNA vaccine designs for optimal adjuvanticity and delivery
Yuki Mochida, Satoshi Uchida
RNA Biology (2024) Vol. 21, Iss. 1, pp. 1-27
Open Access | Times Cited: 5
Emerging advances in delivery systems for mRNA cancer vaccines
Zhimei Jiang, Yanhua Xu, Guangsheng Du, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 287-301
Closed Access | Times Cited: 5
Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications
Yingying Shi, Miaoyuan Shi, Yì Wáng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 5
mRNA vaccines and their delivery strategies: A journey from infectious diseases to cancer
Rama Rao Malla, Mundla Srilatha, Batoul Farran, et al.
Molecular Therapy (2023) Vol. 32, Iss. 1, pp. 13-31
Open Access | Times Cited: 12
Development of Multi-epitope mRNA Vaccine against Clostridioides difficile Using Reverse Vaccinology and Immunoinformatics Approaches
Caixia Tan, Yuanyuan Xiao, Ting Liu, et al.
Synthetic and Systems Biotechnology (2024) Vol. 9, Iss. 4, pp. 667-683
Open Access | Times Cited: 4
In silico development of a novel anti-mutation, multi-epitope mRNA vaccine against MPXV variants of emerging lineage and sub-lineages by using immunoinformatics approaches
Caixia Tan, Jingxiang Zhou, Anhua Wu, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-18
Closed Access | Times Cited: 2
mRNA vaccine development and applications: A special focus on tumors (Review)
Bangjie Chen, Yipin Yang, Xinyi Wang, et al.
International Journal of Oncology (2024) Vol. 65, Iss. 2
Closed Access | Times Cited: 2
Chiral Nanomaterials for Cancer Vaccines
Aihua Qu, Maozhong Sun, Liguang Xu, et al.
Small Methods (2023) Vol. 8, Iss. 3
Closed Access | Times Cited: 7
Generation of an inflammatory niche in an injectable hydrogel depot through recruitment of key immune cells improves efficacy of mRNA vaccines
Emily L. Meany, John H. Klich, Carolyn K. Jons, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
CXCL13 promotes broad immune responses induced by circular RNA vaccines
Jiawu Wan, Caiqian Wang, Zongmei Wang, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 44
Open Access | Times Cited: 2
Thiostrepton-Nanomedicine, a TLR9 Inhibitor, Attenuates Sepsis-Induced Inflammation in Mice
Karina Esparza, Suellen Darc Oliveira, Maricela Castellon, et al.
Mediators of Inflammation (2023) Vol. 2023, pp. 1-11
Open Access | Times Cited: 5
Microbiome-Derived Lipid Nanoparticles for Improved Immunogenicity of mRNA Vaccines
Seok‐Beom Yong, Ok Hyun Park, Sungchan Cho
ACS Materials Letters (2024) Vol. 6, Iss. 4, pp. 1557-1563
Closed Access | Times Cited: 1
Peptide-TLR7/8a-Coordinated DNA Vaccines Elicit Enhanced Immune Responses against Infectious Diseases
栄閣 楊, Tingting Yao, Jinliang Xu, et al.
ACS Biomaterials Science & Engineering (2024) Vol. 10, Iss. 7, pp. 4374-4387
Closed Access | Times Cited: 1
Differential expression and prognostic value of TLR4 in kidney renal clear cell carcinoma
Yaguang Hu, Yanan Gu, Yichen Song, et al.
Molecular and Cellular Probes (2024) Vol. 75, pp. 101959-101959
Open Access | Times Cited: 1
Cancer/Testis Antigens as Targets for RNA-Based Anticancer Therapy
Kyeonghee Shim, Hyein Jo, Dooil Jeoung
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14679-14679
Open Access | Times Cited: 3
Exploring the role of cationic lipids in modulating immunogenicity and vaccine efficacy of mRNA-LNP
Yan Zhou, X. Y. Shan, Renji Gu, et al.
Particuology (2024) Vol. 97, pp. 1-11
Closed Access
Mono‐palmitoyl‐N‐alkylurea ligands as specific activators of human Toll‐like receptor 2/6 heterodimer
Marjolein M. E. Isendoorn, Giulia Castello, Çağla Koç, et al.
ChemBioChem (2024)
Open Access
Advances in mRNA LNP-Based Cancer Vaccines: Mechanisms, Formulation Aspects, Challenges, and Future Directions
Eslam Ramadan, Ali Ahmed, Youssef W. Naguib
Journal of Personalized Medicine (2024) Vol. 14, Iss. 11, pp. 1092-1092
Open Access
Immunogenicity of Recombinant Lipid-Based Nanoparticle Vaccines: Danger Signal vs. Helping Hand
Vladimir Temchura, Jannik T. Wagner, Dominik Damm
Pharmaceutics (2023) Vol. 16, Iss. 1, pp. 24-24
Open Access
Page 1

Scroll to top